Ellevest, Inc. Global Blood Therapeutics, Inc. Transaction History

Ellevest, Inc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 02, 2022	BUY	$32.4 - $68.18 $518 - $1,090	16 Added 533.33%	19 $1,000
Q1 2022 Apr 19, 2022	BUY	$25.68 - $35.59 $77 - $106	3 New	3 $0
Q4 2021 Jan 24, 2022	SELL	$24.9 - $40.26 $3,635 - $5,877	-146 Closed	0 $0
Q3 2021 Oct 19, 2021	BUY	$25.48 - $37.34 $458 - $672	18 Added 14.06%	146 $4,000
Q2 2021 Jul 13, 2021	BUY	$32.46 - $43.42 $779 - $1,042	24 Added 23.08%	128 $4,000
Q1 2021 May 03, 2021	BUY	$38.94 - $50.85 $116 - $152	3 Added 2.97%	104 $4,000
Q4 2020 Feb 04, 2021	BUY	$37.65 - $63.77 $3,463 - $5,866	92 Added 1022.22%	101 $4,000
Q2 2020 Jul 06, 2020	SELL	$48.73 - $81.82 $243 - $409	-5 Reduced 35.71%	9 $1,000
Q1 2020 Apr 13, 2020	BUY	$41.72 - $87.2 $41 - $87	1 Added 7.69%	14 $1,000
Q4 2019 Feb 05, 2020	BUY	$45.7 - $81.86 $594 - $1,064	13 New	13 $1,000

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Ellevest, Inc., based on Form 13F filings with the SEC.

Stay updated on Ellevest, Inc. with notifications on news.